Bientinesi, Riccardo
 Distribuzione geografica
Continente #
NA - Nord America 3.701
EU - Europa 3.646
AS - Asia 2.044
SA - Sud America 366
Continente sconosciuto - Info sul continente non disponibili 102
AF - Africa 71
OC - Oceania 6
Totale 9.936
Nazione #
US - Stati Uniti d'America 3.577
IT - Italia 1.932
SG - Singapore 903
DE - Germania 439
CN - Cina 425
SE - Svezia 322
BR - Brasile 293
FR - Francia 261
VN - Vietnam 201
UA - Ucraina 181
GB - Regno Unito 119
IN - India 109
IE - Irlanda 79
JP - Giappone 76
NL - Olanda 76
CA - Canada 61
ID - Indonesia 59
HK - Hong Kong 54
RU - Federazione Russa 50
BD - Bangladesh 48
FI - Finlandia 43
MX - Messico 32
PL - Polonia 30
AR - Argentina 28
KR - Corea 26
BE - Belgio 25
ES - Italia 23
ZA - Sudafrica 23
IQ - Iraq 22
TR - Turchia 20
CH - Svizzera 14
EG - Egitto 14
EC - Ecuador 12
PH - Filippine 11
PK - Pakistan 11
AT - Austria 10
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
CI - Costa d'Avorio 9
IR - Iran 9
CR - Costa Rica 8
HU - Ungheria 8
MY - Malesia 8
VE - Venezuela 8
CL - Cile 7
MA - Marocco 7
CO - Colombia 6
PE - Perù 6
AU - Australia 5
CZ - Repubblica Ceca 5
HN - Honduras 5
LK - Sri Lanka 5
LT - Lituania 5
UZ - Uzbekistan 5
NP - Nepal 4
DZ - Algeria 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
LU - Lussemburgo 3
OM - Oman 3
PT - Portogallo 3
PY - Paraguay 3
RO - Romania 3
RS - Serbia 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AL - Albania 2
BB - Barbados 2
BY - Bielorussia 2
BZ - Belize 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
GR - Grecia 2
JM - Giamaica 2
KW - Kuwait 2
LB - Libano 2
LV - Lettonia 2
MM - Myanmar 2
NG - Nigeria 2
NI - Nicaragua 2
PA - Panama 2
SA - Arabia Saudita 2
TN - Tunisia 2
TW - Taiwan 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
CV - Capo Verde 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GT - Guatemala 1
IL - Israele 1
Totale 9.826
Città #
Singapore 502
Chandler 365
Ashburn 360
Rome 318
San Jose 294
Milan 193
Beijing 100
Ann Arbor 97
Los Angeles 94
New York 89
Jacksonville 80
Dublin 78
The Dalles 74
Ho Chi Minh City 69
San Mateo 64
Jakarta 55
Lauterbourg 54
Hanoi 50
Wilmington 47
Frankfurt am Main 46
Florence 45
Hefei 45
Hong Kong 45
Naples 39
Tokyo 39
Nanjing 37
Munich 36
São Paulo 33
Atlanta 30
Dallas 29
Kadoma 28
Houston 25
Moscow 25
Nanchang 25
Woodbridge 25
Bari 24
Dearborn 24
Hyderabad 24
Boston 23
Santa Clara 23
Toronto 23
Seattle 22
Bremen 21
Brussels 21
Cattolica 21
Lawrence 21
Bologna 20
Chicago 20
Buffalo 19
Council Bluffs 19
Johannesburg 19
Denver 18
Redwood City 18
Seoul 18
Stockholm 18
Verona 18
Catania 16
Fairfield 16
Marseille 16
Montreal 16
Palermo 16
Turin 16
Düsseldorf 15
Mountain View 15
Princeton 15
Warsaw 15
London 14
Da Nang 13
Kent 13
Lancaster 13
Orem 13
Nürnberg 12
Paris 12
Redmond 12
San Francisco 12
Boardman 11
Cagliari 11
Cairo 11
Chennai 11
Washington 11
Memphis 10
Phoenix 10
Poplar 10
Sesto Fiorentino 10
Abidjan 9
Amsterdam 9
Baghdad 9
Baku 9
Menlo Park 9
Padova 9
Saint Petersburg 9
Augusta 8
Charlotte 8
Genoa 8
Helsinki 8
Manchester 8
Mexico City 8
Ottawa 8
Rio de Janeiro 8
Belo Horizonte 7
Totale 4.468
Nome #
Iniezione transuretrale intracervicale di tossina botulinica tipo A nel trattamento della dissinergia del collo vescicale refrattaria a terapia medica 1.245
Iniezione intracervicale di OnabotulinotossinaA per il trattamento dell'ostruzione primitiva del collo vescicale refrattaria alla terapia medica. Una nuova opzione terapeutica 996
The Impact of Neurogenic Lower Urinary Tract Symptoms and Erectile Dysfunctions on Marital Relationship in Men with Multiple Sclerosis: A Single Cohort Study 299
Perioperative Outcomes of Robotic Radical Prostatectomy with Hugo™ RAS versus daVinci Surgical Platform: Propensity Score-Matched Comparative Analysis 276
Le infezioni delle vie urinarie 258
Robotic versus Open Pyeloplasty: Perioperative and Functional Outcomes 255
Discovery history and clinical development of mirabegron for the treatment of overactive bladder and urinary incontinence 211
The occult urothelial cancer 201
Patient-derived organoids in renal cell carcinoma: A review of methodologies and applications 195
KV7 channels in the human detrusor: channel modulator effects and gene and protein expression 194
OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes 193
Male sexual dysfunction in patients with chronic end-stage renal insufficiency and in renal transplant recipients 185
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma 177
Treatment of bladder neck dissynergia with transurethral injection of OnabotulinumtoxinA: objective and patient-reported results 176
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia treated with intraprostatica onabotulinumtoxinA: 3 month results of a prospective single-armed cohort study 172
Endourethral migration of a Hem-o-Lok Clip after robot-assisted laparoscopic radical prostatectomy 172
[Overactive bladder syndrome: the social and economic perspective] 171
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study 170
Bladder and prostate metastasis from small cell lung cancer: a rare entity 169
Paraneoplastic Dermatomyositis Associated With Panurothelial Transitional Cell Carcinoma: A Case Report and Literature Review 165
Antibiotic prophylaxis in urology 164
Surgery for male urinary incontinence: where are we now and what is in the pipeline? 150
Methylation study of the Paris system for reporting urinary (TPS) categories 142
Simultaneous surgical management of renal cancer with atrial thrombotic extension and severe chronic coronary artery disease: a case report 141
Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine 136
Transalbugineal Artificial Urinary Sphincter: A Refined Implantation Technique to Improve Surgical Outcomes 134
The occult urothelial cancer 134
Current status of robotic urologic surgery in Italy 131
Robot-Assisted Radical Prostatectomy Performed with the Novel Surgical Robotic Platform Hugo™ RAS: Monocentric First Series of 132 Cases Reporting Surgical, and Early Functional and Oncological Outcomes at a Tertiary Referral Robotic Center 130
Paraneoplastic Hyperinsulinism due to Renal Cell Carcinoma Treated With Robotic Nephrectomy 127
18F-Fluoroethylcholine PET/CT Radiomic Analysis for Newly Diagnosed Prostate Cancer Patients: A Monocentric Study 122
Double J stent migration in the contralateral ureter during robotassisted pyeloplasty: an unique complication 122
The new surgical robotic platform HUGOTM RAS: System description and docking settings for robot-assisted radical prostatectomy 121
Lower urinary tract disorders in multiple sclerosis patients: prevalence, clinical features, and response to treatments 121
Pharmacological methods for the preclinical assessment of therapeutics for OAB: an up-to-date review 120
Efficacy and safety of levofloxacin as a treatment for complicated urinary tract infections and pyelonephritis 120
Efficacy and safety of levofloxacin as a treatment for complicated urinary tract infections and pyelonephritis 120
Classification and management of sexual dysfunctions in multiple sclerosis patients: A review of current literature 111
Retigabine induces relaxations of the human bladder detrusor 109
Patient pad count is a poor measure of urinary incontinence compared with 48-h pad test: results of a large-scale multicentre study 109
Prevalence and Antimicrobial Resistance Patterns of Hospital Acquired Infections through the COVID-19 Pandemic: Real-Word Data from a Tertiary Urological Centre 106
Male sling placement for post-prostatectomy incontinence can involve a lengthy learning curve: A multi-outcome assessment via cumulative sum failure analysis 102
Robot-Assisted Radical Prostatectomy Performed with the Novel Hugo™ RAS System: A Systematic Review and Pooled Analysis of Surgical, Oncological, and Functional Outcomes 102
Lifestyle in urology: Cancer 101
Managing urinary incontinence in women - a review of new and emerging pharmacotherapy 98
A multi-surgeon learning curve analysis of overall and site-specific positive surgical margins after RARP and implications for training 97
What can the metaverse do for urology? 96
Objectively improving appropriateness of absorbent products provision to patients with urinary incontinence: The DIAPPER study 96
Neurologic Urinary Incontinence, Lower Urinary Tract Symptoms and Sexual Dysfunctions in Multiple Sclerosis: Expert Opinions Based on the Review of Current Evidences 94
Transalbugineal Artificial Urinary Sphincter: A Refined Implantation Technique to Improve Surgical Outcomes 93
PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG responders 90
Bladder cancer in the time of machine learning: Intelligent tools for diagnosis and management 89
Purely Off-Clamp Partial Nephrectomy: Robotic Approach Better than Open Using a Pentafecta Outcome with Propensity Score Matching 84
Managing urological disorders in multiple sclerosis patients: A review of available and emerging therapies 80
Innovative pharmacotherapies for women with overactive bladder: where are we now and what is in the pipeline? 75
Mirabegron: A review of recent data and its prospects in the management of overactive bladder 67
Management of Small Renal Masses: Literature and Guidelines Review 22
Totale 9.936
Categoria #
all - tutte 35.069
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.069


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022493 0 27 30 52 45 32 17 60 41 40 57 92
2022/20231.109 132 138 90 177 71 120 60 101 125 21 39 35
2023/20241.145 66 147 79 102 67 90 76 129 68 96 86 139
2024/20251.606 71 67 124 65 140 91 98 74 205 179 271 221
2025/20262.974 389 101 158 338 561 152 567 153 177 181 131 66
2026/2027899 125 774 0 0 0 0 0 0 0 0 0 0
Totale 9.936